Background Image
Table of Contents Table of Contents
AI-64310-CRFT Next Page
Information
Show Menu
AI-64310-CRFT Next Page

 




Clinical Research and Forensic Toxicology Application Compendium
1

Table of Contents
2

Clinical Research
3

Application Notes
5

An LC-MS/MS Research Method for the Quantification of Mycophenolic Acid (MPA) in Plasma
7

LC-MS/MS Analysis of Estradiol with Dansyl Derivatization
11

Quantitative Analysis of Low Testosterone Concentrations in Plasma Using the TSQ Quantiva Triple-Stage Quadrupole MS
15

Quantitation of Mycophenolic Acid in Plasma for Research by TurboFlow HPLC-MS/MS
19

Quantification of 17 Antiepileptics and Their Metabolites in Human Plasma by LC-MS/MS for Research
23

Selected-Reaction Monitoring–Mass Spectrometric Immunoassay Analysis of Parathyroid Hormone and Related Variants
29

Automated, High-Throughput LC-MS/MS Workflow for the Analysis of 25-Hydroxyvitamin D2/3 and 3-epi-25-Hydroxyvitamin D3
35

Analysis of 25-Hydroxyvitamin D in Serum Using an Automated Online Sample Preparation Technique with a High-Resolution Benchtop Orbitrap Mass Spectrometer
39

Plasma Free Metanephrines Quantitation with Automated Online Sample Preparation and Liquid Chromatography—Tandem Mass Spectrometry
43

Quantitation of Estrone and Estradiol with Automated Online Sample Preparation and LC-MS/MS
47

Quantitative Analysis of Serum 1α,25-dihydroxy vitamin D byAPPI-LC-MS/MS
53

Quantitative Measurement of Plasma Free Metanephrines by Ion-Pairing Solid Phase Extraction and LC-MS/MS with Porous Graphitic Carbon Column
57

Fast and Sensitive LC-APCI-MS/MS Quantitative Analysis of Estrone and Estradiol in Serum without Chemical Derivatization
61

Quantitative Analysis of Cortisol and Cortisone in Urine by LC-MS/MS
67

Quantitative Analysis of 1,25-dihydroxyvitamin D2 and D3 using Immunoaffinity Extraction with APCI-LC-MS/MS
71

Quantitative LC-MS/MS Analysis of 25-OH Vitamin D3/D2 Comparing 1D Chromatography, 2D Chromatography and Automated Online Sample Preparation
73

Poster Notes
77

The Use of A New Meta-calculation Software for Automated Data Processing of Tandem MS for Inborn Error Metabolism Research
79

Multiplexing Multiple Methods to Maximize Workflow Efficiency in LC-MS Laboratories
87

Full Optimization of LC/MS Methods to Increase Robustness of Complicated Matrix Containing Samples Using Active Flow Management Chromatography
95

Targeted Quantitation of Insulin and Its Therapeutic Analogs for Research
103

Webinars
111

Drug Monitoring Research
113

Application Notes
115

An LC-MS/MS Research Method for the Quantification of Mycophenolic Acid (MPA) in Plasma
117

Quantitation of Immunosuppressant Drugs in Whole Blood Using the Prelude-SPLC System and TSQ Endura Mass Spectrometer for Research
121

Quantitative Analysis of Immunosuppressants in Dried Blood Spots Using the TSQ Endura Triple Quadrupole MS for Research
125

Research Analysis of Clozapine and Norclozapine in Plasma Using Automated Sample Preparation and LC-MS/MS
129

Bioanalytical Assay for Neurotransmitters in Whole Blood by LC-MS/MS
133

Determination of Digoxin in Serum by Liquid Chromatography–Tandem Mass Spectrometry
137

Quantitative Analysis of Mevalonate in Plasma Using LC-MS/MS
141

Validated LC-MS/MS Method for the Analysis of Immunosuppressant Drugs in Whole Blood Using the RECIPE ClinMass® Complete Kit
143

Simultaneous Quantitative Analysis of Four Immunosuppressive Drugs Using High Resolution Accurate Mass LC-MS
145

Improved Quantitative Selectivity of Clenbuterol in Human Urine Using High Resolution on the TSQ Quantum Mass Spectrometer
149

Poster Notes
153

Versatile Solutions to Current Demands for Automated Sample Cleanup, High Throughput, and High-Resolution Chromatography on a Single LC-MS Platform
155

An Improved Immunosuppressant Drug Research Method Based on a Novel SPLC-MS/MS System
163

A Novel On-Line Sample Cleanup and Liquid Chromatography Platform for LC/MS Analysis in the Clinical Research Laboratory
171

LC-MS Quantitative Screening Method for 18 Anabolic Steroids in Oral Fluid Using MS2 Spectra Data Collected with Q Exactive Orbitrap Mass Spectrometer
179

Therapeutic Drug Monitoring of 9 New Anticancer Agents by High-Performance Liquid Chromatography-Tandem Mass Spectrometry
187

The Utilization of Novel Platform in a LC-MS/MS Workflow for the Analysis of Vitamin D, Testosterone, Immunosuppressants, Chemotherapeutics and Cortisol
195

Forensic Toxicology
203

Application Notes
205

Quantitation of Opiates to Low ng/mL Levels in Urine for Forensic Use Using an Affordable, High-Resolution, Accurate-Mass Mass Spectrometer
207

LC-MS/MS Analysis of EtG and EtS in Dilute Urine on the TSQ Endura Triple Quadrupole MS
215

Quantitative Forensic Analysis of Opiates, Opioids, and Their Metabolites in Human Urine Without Hydrolysis
219

Quantitation of Bath Salts/Cathinones in Urine by LC-MS/MS
223

Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites
227

Quantitation of EtG and EtS in Urine by Ion-Pairing LC-MS/MS
235

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine
237

Simultaneous Quantitation of 43 Drugs in Human Urine with a “Dilute-and-Shoot” LC-MS/MS Method
245

Simultaneous Quantitation of 19 Drugs in Human Plasma and Serum by LC-MS/MS
251

Quantitation of Six Opioids in Urine with Super-Dilution and Microflow LC-MS/MS
259

Quantitation of Amphetamines in Urine for SAMHSA Mandated Workplace Drug Testing Using a Triple Stage Quadrupole LC-MS System
263

Quantitation of Synthetic Cannabinoids in Urine Using a Triple Stage Quadrupole LC-MS System in Forensic Toxicology
267

THC-COOH Quantification in Urine Using Dilute and Shoot LC-MS/MS Method forForensic Toxicology
271

Demonstrating High-Performance Quantitative Analysis of Benzodiazepines using Multiplexed SIM with High-Resolution, Accurate Mass Detection on the Q Exactive LC/MS
275

Antidepressants and Neuroleptics Quantitation Using Tandem Mass Spectrometry and Automated Online Sample Preparation
279

Software Driven Quantitative LC-MS Analysis of Opioids in Urine for Forensic Laboratories
283

Quantitation of Six Synthetic Opioids in Urine Using a Triple Stage Quadrupole LC-MS System
291

Quantitation of Six Opiates in Urine Using a Triple Stage Quadrupole LC-MS System
295

Quantitation of 14 Benzodiazepines and Benzodiazepine Metabolites in Urine Using a Triple Stage Quadrupole LC-MS System
299

Targeted Screening of Drugs of Abuse and Toxic Compounds with LC-MS/MS Using Triple Stage Quadrupole Technology
303

Simultaneous Analysis of Opiates and Benzodiazepines in Urine in Under 3 Minutes per Sample Using LC-MS/MS
307

Quantitation of Urinary Ethyl Glucuronide and Ethyl Sulfate Using Ultrahigh Resolution LC-MS
309

Quantitation of 12 Benzodiazepines and Metabolites in Urine Using Ultrahigh Resolution LC-MS for Forensic Toxicology Use
311

Screening and Quantification of Multiple Drugs in Urine Using Automated Online Sample Preparation and Tandem Mass Spectrometry
313

Determination of LSD and Its Metabolites in Human Biological Samples by Liquid Chromatography–Tandem Mass Spectrometry
315

A Quantitative Test for Multiple Classes of Illicit Drugs and Their Primary Metabolites in Human Biological Fluids by LC-MS/MS for Forensic Use
319

Quantitation of Fentanyl and Norfentanyl from Urine Using On-line High Throughput System
323

Forensic Analysis of Opiates in Whole Blood by LC-MS/MS Using Automated, Online Sample Preparation
325

A Complete Toxicology Screening Procedure for Drugs and Toxic Compounds in Urine and Plasma Using LC-MS/MS
327

Rapid Analysis of Opiates from Low Volume Whole Blood Samples by LC-MS/MS Utilizing TurboFlow Methods
335

Forensic Toxicology Screening with LC-MS/MS and Automated Online Sample Preparation
339

Screening for Drugs and Toxic Compounds: Comparison between LC-MS/MS, HPLC-DAD, and Immunoassay
341

Screening of 20 Benzodiazepines and Four Metabolites in Whole Blood using UHPLC-MS/MS
345

Quantitative LC-MS Analysis of 14 Benzodiazepines in Urine Using TraceFinder 1.1 Software and High Resolution Accurate Mass
347

A Fully Automated LC-MS Screening System using Automated Online Sample Preparation for Forensic Toxicology
355

Analysis of Multiple Illicit Drugs, Methadone, and their Metabolites in Oral Fluid Using a Linear Ion Trap Mass Spectrometer
357

Screening Drugs and Toxic Compounds with LC-MS/MS: An Alternative to LC-UV for Research Toxicology Labs
361

Poster Notes
365

Direct Analysis using Paper-Spray Mass Spectrometry: Method Development for the Rapid Screening of Drugs of Abuse for Forensic Toxicology
367

Confirmatory Determination of Buprenorphine and Norbuprenorphine in Urine Using A High-Throughput LC-HRAM-MS/MS Forensic Methodology
375

Evaluating New ToxFinder Data Processing Software in Targeted Screening Applications Implemented on Orbitrap Ultra High Resolution Mass Spectrometers and Triple Quadrupole Mass Spectrometers
383

Quantitation of 47 Forensic Compounds in Urine by HPLC-MS
393

Multiplexing Multiple Methods to Maximize Workflow Efficiency in LC-MS Laboratories
401

LC/MS/MS Research Method for 14 Antidepressants Utilizing Dried Blood Spots
409

Verification of an LC-MS/MS Forensic Method for 19 Opioids, Opiates, and Their Metabolites in Human Urine Without Hydrolysis
417

Advantages of Ultra-High-Resolution Q Exactive Mass Spectrometer in Analysis of Unlimited Number of Compounds in Urine Quantitative Screening Application for Forensics
425

Quantitation of Seven Designer Cathinones in Urine Using Q Exactive Mass Spectrometer
431

High-Resolution, Accurate-Mass Forensic Toxicology Screening in Blood Samples Using a Q Exactive Mass Spectrometer
439

Verification of the Simultaneous Analysis of Heroin Addiction Treatment Compounds Using LC/MS/MS with a New Prelude SPLC™ System
447

Quantitative Confirmatory Analysis of the NIDA 5 Panel Using Prelude SPLC System and TSQ Quantum Ultra MS
455

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation
463

Webinars
471

Sports Anti-Doping
473

Application Notes | Poster Notes
475

Detection of Stanozolol Glucuronides in Human Sports Drug Testing by Means of High-Resolution, Accurate-Mass Mass Spectrometry
477

Screening in Equine Doping Control Analysis with Ultrahigh Resolution and Accurate Mass
483

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine
487

Rapid Quantitative and Confirmational Screening for Drugs in Race Horse Urine by ESI-LC-MS/MS and MS3
495

Developing a Method to Protect the Integrity of Racing Using Targeted SRM: Detection and Quantitation of rhEPO/DPO in Horse Plasma
503

Targeted Quantitation of Insulin and Its Therapeutic Analogs for Research
507

Analysis of Equine Doping Using TurboFlow Technology and Multiplexing with LC-MS/MS
515

Peer Reviewed Articles
517

Webinars
519

Translational Research
521

Application Notes
523

Automated High-Throughput Data Processing for Targeted Multiplexed Insulin Analog Detection and Quantification
525

Selected-Reaction Monitoring–Mass Spectrometric Immunoassay Analysis of Parathyroid Hormone and Related Variants
537

Targeted Kinase Inhibitor Profiling Using a Hybrid Quadrupole-OrbitrapMass Spectrometer
543

Peer Reviewed Articles
551

Poster Notes
553

Improving Throughput for Highly Multiplexed Targeted Quantification Methods Using Novel API-Remote Instrument Control and State-Model Data Acquisition Schemes
555

Targeted Quantitation of Insulin and Its Therapeutic Analogs for Research
563

Enrichment of EGFR/PI3K/AKT/PTEN Proteins for Research using Immunoprecipitation and with Mass Spectrometry-based Analysis
571

Real-Time Qualitative and Quantitative Global Proteomics Profiling Using a Hybrid Data Acquisition Scheme
579

Characterizing Qualitative and Quantitative Global Changes in the Aging Heart Using pSMART, a Novel Acquisition Method
587

Targeted Multiplexed Protein Quantitation Using Serial Immunoaffinity Extraction Coupled to LC-MS
593

Improving Throughput for Targeted Quantification Methods by Intelligent Acquisition
601

Spectrum Library Retention Time Prediction Based on Endogenous Peptide Standards
609

Comprehensive Peptide Searching Workflow to Maximize Protein Identifications
615

High-Resolution, Accurate-Mass (HR/AM) and Intelligent Acquisition-Enabled Global Discovery and Quantification of Histones, Histone PTMS, and Histone Modification Enzymes in Mesenchymal Stem Cells
625

A Phospho-Peptide Spectrum Library for Improved Targeted Assays
633

Improving Label-Free Quantification of Plasma and Serum Proteins Using a High-Resolution Hybrid Orbitrap Mass Spectrometer
641

Detection of Cellular Response to an in vitro Challenge with Bacterial Gram-Negative Lipopolysaccharides (LPS) in Peripheral Blood Mononuclear Cells (PBMCs) for Biomarker Research
649

Webinars
657